News
Liver transplant improves survival for certain patients with colorectal cancer liver metastases
August 2023 A recent study demonstrated that a liver transplant provided a 10-year overall survival (OS) rate of more than...
What does Research Say? The Impact of Meditation on Cancer-Treatment Side Effects.
If you or a loved one has been diagnosed with cancer, you know that it can have a large impact...
Fruquintinib significantly extends survival in refractory metastatic colorectal cancer
July 2023 Fruquintinib is a small molecule inhibitor of the vascular endothelial growth factor receptors(VEGFs). VEGFs are involved in the...
Chemotherapy sequence in advanced colorectal cancer
July 2023 Phase III studies have shown the advantage of combining chemotherapy agents fluorouracil (5-FU) with folinic acid (leucovorin) and...
Patient-reported outcomes from the PROSPECT trial: treatment for locally advanced rectal cancer
A recent analysis from the PROSPECT trial examined trends in patient-reported outcomes among those who received neoadjuvant FOLFOX (fluorouracil, leucovorin,...
Trastuzumab deruxtecan shows activity in HER2+ metastatic colorectal cancer
The DESTINY-CRC01 trial was one of the first studies to show that the targeted therapy trastuzumab deruxtecan (T-DXd) was able...
Get social
Liver transplant improves survival for certain patients with colorectal cancer liver metastases
August 2023 A recent study demonstrated that a liver transplant provided a 10-year overall survival (OS) rate of more than...
What does Research Say? The Impact of Meditation on Cancer-Treatment Side Effects.
If you or a loved one has been diagnosed with cancer, you know that it can have a large impact...
Fruquintinib significantly extends survival in refractory metastatic colorectal cancer
July 2023 Fruquintinib is a small molecule inhibitor of the vascular endothelial growth factor receptors(VEGFs). VEGFs are involved in the...
Chemotherapy sequence in advanced colorectal cancer
July 2023 Phase III studies have shown the advantage of combining chemotherapy agents fluorouracil (5-FU) with folinic acid (leucovorin) and...
Patient-reported outcomes from the PROSPECT trial: treatment for locally advanced rectal cancer
A recent analysis from the PROSPECT trial examined trends in patient-reported outcomes among those who received neoadjuvant FOLFOX (fluorouracil, leucovorin,...
Trastuzumab deruxtecan shows activity in HER2+ metastatic colorectal cancer
The DESTINY-CRC01 trial was one of the first studies to show that the targeted therapy trastuzumab deruxtecan (T-DXd) was able...
